Please select the option that best describes you:

What approach would you take for patients with metastatic castration-resistant prostate cancer with marked PSA response (undetectable) on docetaxel, but radiographic progression in bone metastases?  



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more